Sponsors

ITOC12 thankfully acknowledges the support of the following companies and institutions

(listing in alphabetical order)

ABclonal is a leading life science company specializing in high-quality antibodies, proteins, and molecular biology reagents. With strong in-house R&D, advanced production platforms, and strict quality control systems, ABclonal supports researchers worldwide in life science research, diagnostics, and biopharmaceutical development, delivering reliable solutions for scientific discovery and innovation.

EUR 3.800,-

Revvity and BioLegend (from Revvity) provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in flow cytometry, translational multiomics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia, and governments. Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook, and Instagram.

EUR 3.800,-

Biospace Lab develops innovative real-time preclinical imaging systems, including bioluminescence, NIR I/II fluorescence, and autoradiography. Founded in 1989 by Nobel laureate Georges Charpak, the company pioneered digital autoradiography and has since remained at the forefront of optical imaging innovation. Based near Paris, Biospace Lab serves leading pharmaceutical companies and academic institutions worldwide.

EUR 2.200,-

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.com.

EUR 9.500,-

As a global health care company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. Our Lovo and Cue Cell Processing Systems are designed to be efficient and scalable, aiming to deliver cell and gene therapies to patients quickly and reliably. Link to website: Fresenius Kabi USA - Cell and Gene Therapy Technologies

EUR 1.500,-

Gilead and Kite Oncology are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer. Read more: https://www.gileadsciences.de/

EUR 3.500,-

GSK is a global biopharma company. Our purpose is to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company with strong momentum, where outstanding people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. At the heart of this is our R&D focus on the science of the immune system and use of advanced technologies to drive innovation – preventing and treating the most challenging diseases. We invest in four core therapeutic areas: Respiratory, Immunology & Inflammation; Oncology; HIV and Infectious Diseases – to significantly impact health at scale. From basic research, clinical development to manufacturing and commercialization of our products, GSK is closely associated with Germany as a business and science location: GSK has facilities in Munich, Heidelberg, Berlin, Dresden and Marburg. We owe our success to the incredible dedication and commitment of our global workforce. We employ over 65,000 employees across 75 markets worldwide, including over 2,900 employees in Germany. Social responsibility and sustainability are at the heart of our corporate philosophy. This is the reason why we place such great emphasis on promoting projects at a local level. Our global headquarter is based in London, UK.

https://de.gsk.com, http://www.gsk.com, YouTube: GSK Deutschland - YouTube

EUR 19.500,-

The ibidi portfolio comprises a broad range of slides for high-resolution cell microscopy, along with specialized assays for studying cell migration, performing 3D cell culture, and cultivating cells under flow conditions.

Precise microfluidic systems and compact, resource-saving stage top incubation systems enable realistic simulation of both static and dynamic physiological conditions.

Luci, the new ibidi Micro Illumination System, brings light-induced microfabrication into every lab.

EUR 3.800,-

InVivo Biotech Services GmbH a Bruker company, is a CDMO partner delivering high-performance antibody solutions for oncology research and preclinical development. We combine advanced in vivo and ex vivo technologies, disease-relevant cancer models, and scalable development workflows to support biotech and pharmaceutical programs from target validation to lead optimization. With a focus on speed, reliability, and translational impact, we help our partners reduce development risk and accelerate high-quality antibody candidates toward clinical success

EUR 8.000,-

Janvier Labs provides a comprehensive portfolio of mouse models for preclinical evaluation of cancer immunotherapies, including immune checkpoint inhibitors, monoclonal and multi-specific antibodies, and cell-based therapies. Our offering includes immunodeficient mouse strains that can be engrafted with a functional human immune system to establish xenograft tumor models. Additionally, Janvier Labs offers humanized Knock-In mouse models expressing human-specific targets, such as immune checkpoints and T-cell stimulatory molecules, allowing the assessment of efficacy and safety of novel immunotherapeutic agents in a fully immunocompetent system.

EUR 1.500,-

Johnson & Johnson In Germany, J&J Innovative Medicine has about 1,000 employees and is the number 2 among research-based pharmaceutical companies.

Every day, J&J invests around 37.1 million U.S. dollars worldwide in the research and development of new drugs, including in the fields of oncology, immunology and neuroscience. 15 of the company's active ingredients are on the 23rd WHO Model List of Essential Medicines. In 2024, approximately 500,000 patients in Germany were treated with a prescription product from J&J.

EM-159888

GOLD SPONSOR | EUR 27.000,-

Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures.

Widely recognized for optical precision and innovative technology, the company is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopy.

URL: https://www.leica-microsystems.com/

EUR 3.000,-

MedChemExpress (MCE) is a supplier of research chemicals and bioactive compounds with 10+ warehouses worldwide. It offers 100,000+ high-quality inhibitors/agonists targeting 1,000+ proteins across 20+ pathways, alongside recombinant proteins, dyes, and assay kits. MCE provides custom synthesis (ADCs, PROTACs) and a comprehensive drug discovery platform featuring 200+ compound libraries, advanced screening (HTS, AI), and profiling services to support global research.

EUR 3.800,-

Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, transforming scientific discoveries into practical treatments for personalized medicine. With over 35 years of expertise, it supports biomedical discoveries and translates them into clinical applications, enhancing patient access to new therapies. Miltenyi Biotec focuses on offering integrated solutions for complex challenges in treating cancers, autoimmune diseases, and inherited disorders. Its Miltenyi Bioindustry division provides expert guidance to therapy developers efficiently from process development to commercialization. Headquartered in Bergisch Gladbach, it employs 4,700 people across 24 countries.

EUR 3.800,-

At Pfizer, we bring therapies to people that extend and significantly improve their lives. We work across developed and emerging markets to advance prevention, treatments and cures that challenge the most feared diseases of our time. As one of the world's innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care. In Germany, more than 3,000 employees work at the headquarters in Berlin, the distribution center in Karlsruhe and the manufacturing site in Freiburg.

EUR 3.800,-

Pixelgen Technologies AB is on a mission to deliver biology at the highest resolution by understanding the molecular basis of cellular function with new tools and technologies that decipher the protein interactomics of single cells in unprecedented ways. The company’s patented Proximity Network Assay delivers nanoscale spatial analysis of immune cell proteins at ultra-high capacity and underpins the Pixelgen Proxiome Kit for precision medicine. Pixelgen was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs and is venture-backed.

EUR 5.300,-

MedChemExpress (MCE) is a supplier of research chemicals and bioactive compounds with 10+ warehouses worldwide. It offers 100,000+ high-quality inhibitors/agonists targeting 1,000+ proteins across 20+ pathways, alongside recombinant proteins, dyes, and assay kits. MCE provides custom synthesis (ADCs, PROTACs) and a comprehensive drug discovery platform featuring 200+ compound libraries, advanced screening (HTS, AI), and profiling services to support global research.

EUR 3.800,-

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly translate science into medicine has led to eleven approved treatments in the European Union and more than 45 product candidates in development. Learn more at www.Regeneron.com.

EUR 10.000,-

MedChemExpress (MCE) is a supplier of research chemicals and bioactive compounds with 10+ warehouses worldwide. It offers 100,000+ high-quality inhibitors/agonists targeting 1,000+ proteins across 20+ pathways, alongside recombinant proteins, dyes, and assay kits. MCE provides custom synthesis (ADCs, PROTACs) and a comprehensive drug discovery platform featuring 200+ compound libraries, advanced screening (HTS, AI), and profiling services to support global research.

EUR 3.800,-

At Svar Life Science, we empower drug development with advanced functional Bioassays & Services enabling scientists to streamline Drug Screening & Characterization, precise Potency Testing and NAb Detection. Solutions include topics like the Complement System Fc-mediated MOAs (ADCC, ADCP, CDC), T-cell engagement (CD3), Insulin, Cytokines or Growth Factors, and gene and cell therapy solutions. With our de novo reporter cell line generation and GMP-compliant assay development & validation services, we cover the complete value chain.

EUR 800,-

MedChemExpress (MCE) is a supplier of research chemicals and bioactive compounds with 10+ warehouses worldwide. It offers 100,000+ high-quality inhibitors/agonists targeting 1,000+ proteins across 20+ pathways, alongside recombinant proteins, dyes, and assay kits. MCE provides custom synthesis (ADCs, PROTACs) and a comprehensive drug discovery platform featuring 200+ compound libraries, advanced screening (HTS, AI), and profiling services to support global research.

EUR 3.800,-

Ultrabright develops next-generation signal amplification reagents that dramatically increase sensitivity in molecular detection. Built on DNA-nanotechnology, our "ultra-beacons" act as molecular photomultipliers, delivering exceptionally bright, low-background signals in flow cytometry, immunoassays, or liquid biopsy workflows. The platform integrates seamlessly into existing assays, enabling detection of rare biomarkers and low-expressing cellular targets currently beyond industry limits.

EUR 3.500,-

MedChemExpress (MCE) is a supplier of research chemicals and bioactive compounds with 10+ warehouses worldwide. It offers 100,000+ high-quality inhibitors/agonists targeting 1,000+ proteins across 20+ pathways, alongside recombinant proteins, dyes, and assay kits. MCE provides custom synthesis (ADCs, PROTACs) and a comprehensive drug discovery platform featuring 200+ compound libraries, advanced screening (HTS, AI), and profiling services to support global research.

EUR 3.800,-

Wolfgang Wilmanns Stiftung

The purpose of the Wolfgang Wilmanns Foundation is the support of leukaemia and tumour research at the universities in Munich with the involvement of the TZM. This purpose is particularly fulfilled through awarding prizes to young researchers or research groups at the universities in Munich for outstanding performance in this area. The foundation is a non-profit organisation. Click to read more.

EUR 1.000,-

We herewith confirm that all sponsorship income is free of any attempt to influence the programme, individual sessions, subjects for discussions, content or choice of faculty members